During the past decade, Dedinje Cardiovascular Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dedinje Cardiovascular Institute" #1 sponsor was "Actelion" with 2 trials, followed by "Advanz Pharma" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Weill Medical College of Cornell University" with 2 trials sponsored and "Berlin Cures GmbH" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dedinje Cardiovascular Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Coordinating Centre for Clinical Trials, Charité" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Dedinje Cardiovascular Institute" are "Atrial Fibrillation" (3 trials), "Heart Diseases" (3 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Dedinje Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "Dedinje Cardiovascular Institute" are "Drug" (9 trials), "Device" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Multiple arterial grafting" (2 trials), "Single arterial graft" (2 trials), "Allopurinol 100 up to 600mg/day" (1 trials) and "Amiodarone Injection:" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dedinje Cardiovascular Institute" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 4 active trials in "Dedinje Cardiovascular Institute". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Dedinje Cardiovascular Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dedinje Cardiovascular Institute, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".